Meet the speaker #5 | Perturb 2027

Director of the Gladstone-UCSF Institute of Genomic Immunology and Professor in the UCSF Department of Medicine, get to know more about Dr. Marson’s research with genetically modified T cells.

thumbnail depicting Alex Marson from UCSF, speaker for Perturb 2027

Alex Marson

Alex Marson is Director of the Gladstone-UCSF Institute of Genomic Immunology and Professor in the UCSF Department of Medicine, Division of Infectious Diseases. He serves as the Director of the Parker Institute of Cancer Immunotherapy at Gladstone, among other roles. Dr. Marson’s work aims to understand the genetic programs controlling human immune cell function in health and disease, with an emphasis on developing and applying CRISPR genome engineering tools to primary immune cells, especially T cells. Combining genomics and gene editing approaches, the lab works to assess the consequences of coding and noncoding genetic variation on immune cell function and autoimmune disease risk and to genetically engineer human immune cells to target cancer, autoimmunity, and infectious diseases.

Learn more about pricing and abstract submission deadlines at:

More news

Meet the speaker #6 | Perturb 2027

Professor at UCSF and a Core Investigator at the Arc Institute, get to know more about Dr. Gilbert, an early pioneer in repurposed CRISPR systems that are used to turn genes on and off (CRISPRa/i and CRISPRoff/on).

Myllia announces newly formed board with industry leaders

Single-cell commercial leader Simone Günther, US biotech veteran Sandy Zweifach, and Werner Lanthaler (Wlanholding) join to guide Myllia's next phase of growth

Meet the speaker #4 | Perturb 2027

With a career that spans UCSF, MIT and Gladstones Institutes, get to know more about Dr. Christina Theodoris’s career and research with AI models focused on understanding gene network dynamics.